Scheiner Zachary
SEC insider (Form 3/4/5 filer). CIK 0001816523. Director at LENZ Therapeutics, Inc. (LENZ) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in BOSTON, MA.
Companies Scheiner Zachary has filed insider reports for
- LENZ Therapeutics, Inc. (LENZ): Director
- Nkarta, Inc. (NKTX): Director
- SpyGlass Pharma, Inc. (SGP): Director
Scheiner Zachary
CIK: 0001816523
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 15, 2026LENZ
LENZ Therapeutics, Inc.
AwardDirectStock Option (right to buy)
22.1K shares- - Jun 10, 2026NKTX
Nkarta, Inc.
AwardDirectStock Option (right to buy)
37K shares- - Feb 5, 2026SGP
SpyGlass Pharma, Inc.
AwardDirectStock Option (right to buy)
27.4K shares- - Jun 11, 2025LENZ
LENZ Therapeutics, Inc.
AwardDirectStock Option (right to buy)
13.5K shares- - Jun 5, 2025NKTX
Nkarta, Inc.
AwardDirectStock Option (right to buy)
46K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  LENZ LENZ Therapeutics, Inc. | Award Stock Option (right to buy) | 22,100 | - | - | Direct |
| Jun 10, 2026 |  NKTX Nkarta, Inc. | Award Stock Option (right to buy) | 37,000 | - | - | Direct |
| Feb 5, 2026 |  SGP SpyGlass Pharma, Inc. | Award Stock Option (right to buy) | 27,400 | - | - | Direct |
| Jun 11, 2025 | LENZ LENZ Therapeutics, Inc. | Award Stock Option (right to buy) | 13,500 | - | - | Direct |
| Jun 5, 2025 | NKTX Nkarta, Inc. | Award Stock Option (right to buy) | 46,000 | - | - | Direct |
1-5 of 5 transactions